At the 2022 ASCO Annual Meeting, Healio honored AccessHope with its Clinical Innovation Award as part of the inaugural Healio Disruptive Innovators in hematology/oncology. This award recognizes our exemplary work to extend access to expert clinical decision support to improve quality of life and health outcomes for people with cancer, regardless of location. In this article celebrating this year’s Disruptive Innovators, H. Jack West, M.D., medical director of AccessHope, reflected on how we are transforming cancer care for both patients and their oncologists.
